Neural tube defects: Pathogenesis and folate metabolism

Journal of Association of Physicians of India

Volumn 53, Issue FEB, 2005, Pages 127-135

  Pulikkunnel, Scaria T ^a   Thomas, S V ^b  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

5,6,7,8-TETRAHYDROFOLIC ACID; FOLIC ACID; TETRAHYDROFOLIC ACID; TETRAHYDROFOLIC ACID DERIVATIVE;

DIET SUPPLEMENTATION; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; METABOLISM; NEURAL TUBE DEFECT; PREGNANCY; REVIEW; RISK FACTOR;

DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; FOOD, FORTIFIED; HUMANS; NEURAL TUBE DEFECTS; PREGNANCY; RISK FACTORS; TETRAHYDROFOLATES;

EID: 19844380349     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Moore CA, Li S, Li Z, Hong SX, Gu HQ, Berry RJ, et al. Elevated rates of severe neural tube defects in high prevalence areas in northern China. Am J Med Gen 1997;73:113-18.
2. Verma IC. High incidence or neural tube defects in North India. Lancet 1978;i:879.
3. Hunt GM, Oakeshott P. Outcome in people with open spina bifida at age 35: prospective community based cohort study. BMJ 2003;326:1365-1366.
4. Waitzman NJ, Romano PS, Scheffler RM. Estimates of economic costs of birth defects. Inquiry 1994;31:188-205.
5. Nieuwkoop PD. The neural induction process: Its morphogenetic aspects. Int J Dev Biol 1999;43:615-623.
6. Bachiller D, Klingensmith J, Kemp C, Belo JA, Anderson RM, May SR, McMohan JA, McMohan AP, Harland RM, Rossant J, De Roberts EM. The organizer factors Chordin and Noggin are required for mouse forebrain development. Nature 2000;403:658-661.
7. Davidson LA, Keller RE. Neural tube closure in Xenopus laevis involves medial migration, directed protrusive activity, cell intercalation and convergent extension. Development 1999;126:4547-4556.
8. Jacobson AG, Gordon R. Changes in the shape of the developing vertebrate nervous system analysed experimentally, mathematically, and by computer simulation. J Exp Zool 1976;197:191-246.
9. Schoenwolf GC. Cell movements during neurulation in avian embryos. Development 1991;2:(Suppl.)157-168.
10. Jacobson AG. Some forces that shape the nervous system. Zoon 1978;6:13-21.
11. Smith JL, Schoenwolf GC. Neurulation: Coming to closure. Trends Neurosci 1997;20:510-517.
12. Nagele RG, Hunter E, Bush K, Lee HY. Studies on the mechanism of neurulation in the chick: Morphometric analysis of force distribution within the neuroepithelium during neural tube formation. J Exp Zool 1987;244:425-436.
13. Schoenwolf GC, Folson D, Moe A. A reexamination of the role of microfilaments in neurulation in the chick embryo. Anat Rec 1988;220:87-102.
14. Ferreira MC, Hilfer SR. Calcium regulation of neural fold formation: Visualisation of the actin cytoskeleton in living chick embryos. Dev Biol 1993;159:427-440.
15. Hildebrand JD, Soriano P. Shroom, a PDZ domain-containing actin-binding protein, is required for neural tube morphogenesis in mice. Cell 1999;99:485-497.
16. Van Straaten HWM, Janssen HCJP, Peeters MCE, Copp AJ, Hekking JWM. Neural tube closure in chick embryo is multiphasic. Dev Dynamics 1996;207:309-318.
17. Schoenwolf GC, Alvarez IS. Roles of neuroepithelial cell rearrangement and division in shaping of the avian neural plate. Development 1989;106:427-439.
18. Van Straaten HW, Hekking JW, Wiertz Hoessels EJ, Thors F, Drukker J. Effect of the notochord on the differentiation of a floor plate area in the neural tube of the chick embryo. Anat Embryol Berl 1988;177:317-324.
19. Smith JL, Schoenwolf GC. Notochordal induction of cell wedging in the chick neural plate and its role in neural tube formation. J Exp Zool 1989;250:49-62.
20. Placzek M, Dodd J, Jessell TM. The case for floor plate induction by the notochord. Curr Opin Neurobiol 2000;10:15-22.
21. Schoenwolf GC, Smith JL. Mechanisms of neurulation: Traditional viewpoint and recent advances. Development 1990;109:243-270.
22. Wallingford JB, Harland RM. Neural tube closure requires Dishevelled-dependent convergent extension of the midline. Development 2002;129:5815-5825.
23. Hackett DA, Smith JL, Schoenwolf GC. Epidermal ectoderm is required for full elevation and for convergence during bending of the avian neural plate. Dev Dynamics 1997;210:397-406.
24. Alvarez IS, Schoenwolf GC. Expansion of surface epithelium provides the major extrinsic force for bending of the neural plate. J Exp Zool 1992;261:340-348.
25. Van Straaten HWM, Peeters MCE, Szpak KWF, Hekking JWM. Initial closure of the mesencephalic neural groove in the chick embryo involves a releasing zipping-up mechanism. Dev Dynamics 1997;209:333-341.
26. Golden JA, Chernoff GF. Anterior neural tube closure in the mouse: Fuel for disagreement with the classical theory. Clin Res 1983;31:127a.
27. Golden JA, Chernoff GF. Intermittent pattern of neural tube closure in two strains of mice. Teratology 1993;47:73-80.
28. Peeters MCE, Viebahn C, Hekking JWM, Van Straaten HWM. Neurulation in the rabbit embryo. Anat Embryol 1998;197:167-175.
29. O'Rahilly R, Müller. Bidirectional closure of the rostral neuropore in the human embryo. Am J Anat 1989;184:259-268.
30. Seller MJ. Multi-site neural tube closure in humans and maternal folate supplementation. Am J Med Genet 1995;58:222-224.
31. Campbell LR, Sohal GS. The pattern of neural tube defects created by secondary reopening of the neural tube. J Child Neurol 1990;5:336-340.
32. Little J, Elwood JH. Socio-economic status and occupation. In: Elwood JM, Little J, Elwood JH, eds. Epidemiology and control of neural tube defects of Monographs in epidemiology and biostatistics. Oxford, England: Oxford University Press, 1992:20:456-520.
33. Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 1990;85:1-9.
34. Edwards MJ, Shiota K, Smith MSR, Walsh DA. Hyperthermia and birth defects. Reprod Toxicol 1995;9:411-425.
35. Graham JM Jr, Edwards MJ, Edwards MJ. Teratogen update: gestational effects of maternal hyperthermia due to febrile illnesses and resultant patterns of defects in humans. Teratology 1998;58:209-221.
36. Shaw GM, Velie EM, Schaffer D. Risk of neural tube defectaffected pregnancies among obese women. JAMA 1996;275:1093-1096.
37. Frey L, Hauser WA. Epidemiology of Neural Tube Defects. Epilepsia 2003;44(suppl 3):4-13.
38. Velie EM, Block G, Shaw GM, Samuels SJ, Schaffer DM, Kulldorff M. Maternal supplemental and dietary zinc intake and the occurrence of neural tube defects in California. Am J Epidemiol 1999;150:605-616.
39. Hibbard BM. The role of folic acid in pregnancy: With particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Br Commonwlth 1964;71:529-542.
40. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child 1976;51:944-950.
41. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, Read AP, Fielding DW. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980;1:339-340.
42. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomised control trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J 1981;282:1509-1511.
43. Smithells RW, Nevin NC, Seller MJ, Sheppard S, Harris R, Read AP, Fielding DW, Walker S, Schorah CJ, Wild J. Further experience of vitamin supplementation for prevention of neural-tube defect recurrences. Lancet 1983;1:1027-1031.
44. MRC Vitamin Study Research Group. Prevention of neuraltube defects: Results of the Medical Research Council vitamin study. Lancet 1991;338:131-137.
45. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-1835.
46. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong L-YC, Gindler J, Hong S-X, Correa A. Prevention of neural-tube defects with folic acid in China. N Engl J Med 1999;341:1485-1490.
47. Molloy AM, Weir DG, Scott JM. Homocysteine, folate enzymes and neural tube defects. Hematologia 1999;84:53-56.
48. De Marco, Calceno MG, Moroni A, Merello E, Raso A, et al. Reduced Folate carrier polymorphism (80 A® G) and neural tube defects. Eur J Hum Genet 200311:245-252.
49. Heil SG, Van der Put NMJ, Trijbels FJM, Gabreëls FJM, Blom HJ. Molecular genetic analysis of human folate receptors in neural tube defects. Eur J Hum Genet 1999;7:393-396.
50. Rothenberg SP, da Costa MP, Sequeira JM, Cracco J, Roberts JL, Weedon J, Quadros EV. Autoantibodies against folate receptors in women with a pregnancy complicated by a neural tube defect. N Engl J Med 2004;350:134-142.
51. Goyette P, Sumner JS, Milos R, Duncan AMV, Rosenblatt DS, Matthews RG, Rozen R. Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification. Nat Genet 1994;7:195-200.
52. Kang S-S, Wong PWK, Susmano A, Sora J, Nurusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: An inherited risk-factor for coronary artery disease. Am J Hum Genet 1991;48:536-545.
53. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. A candidate genetic risk-factor for vascular disease : A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-113.
54. Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, Van den Heuvel LP, Mariman ECM, Den Heyer M, Rozen R, Blom HJ. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070-1071.
55. Van der Put NMJ, Van den Heuvel LP, Steegers-Theunissen RPM, Trijbels FJM, Eskes TKAB, Mariman ECM, Den Heyer M, Blom HJ. Decreased methylenetetrahydrofolate reductase activity due to the C677T mutation in families with spina bifida offspring. J Mol Med 1996;74:691-694.
56. Botto LD, Yang Q. MTHFR and birth defects: a HuGE review. Atlanta: Centers for Disease Control and Prevention, 1999.
57. Nelen WLDM, Blom HJ, Thomas CMG, Steegers EAP, Boers GHJ, Eskes TKAB. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr 1998;128:1336-1341.
58. Van der Put NMJ, Gabreëls F, Stevens EMB, Smeitink JAM, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Blom HJ. A second common mutation in the methylenetetrahydrofolate reductase gene: A risk factor for neural tube defects? Am J Hum Genet 1998;62:1044-1051.
59. Stegmann K, Ziegler A, Ngo ETKM, Kohlschmidt N, Schroter B, Ermert A, Koch MC. Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD). Am J Med Genet 1999;87:23-29.
60. Van der Put NMJ, van der Molen EF, Kluijtmans LAJ, Heil SG, Trijbels FJM, Eskes TKAB, van Oppenraaij-Emmerzaal D, Banerjee R, Blom HJ. Sequence analysis of the coding region of human methionine synthase: Relevance to hyperhomocysteinemia in neural-tube defects and vascular disease. Q J Med 1997;90:511-517.
61. Chen LH, Liu ML, Huang HY, Chen LS, Korenberg J, Shane B. Human methionine synthase: cDNA cloning, gene localisation and expression. J Biol Chem 1997;272:3628-3634.
62. Harmon DL, Shields DC, Woodside JV, McMaster D, Yarnell JW, Young IS, Peng K, Shane B, Evans AE, Whitehead AS. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 1999;17:298-309.
63. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, Heng HHQ, Rommens JM, Scherer SW, Rosenblatt DS, Gravel RA. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA 1998;95:3059-3064.
64. Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, Gravel RA, Rozen R. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 1999;67:317-323.
65. Hol FA, Van der Put NM, Geurds MP, Heil SG, Trijbels FJ, Hamel BC, Mariman EC, Blom HJ. Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD in patients with NTD. Clin Genet 1998;53:119-125.
66. Kraus JP. Cystathionine beta synthase mutations in homocysteinuria. Hum Mut 1999;13:362-375.
67. Lammer EJ, Sever LE, Oakley GP Jr. Teratogen update: valproic acid. Teratology 1987;35:465-73.
68. Wegner C, Nau H. Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis. Neurology 1992;42(4 suppl 5):17-24.
69. Martin ML, Regan CM. The anticonvulsant valproate teratogen restricts the glial cell cycle at a defined point in the mid-G1 phase. Brain Res 1991;554:223-8.
70. Regan CM, Gorman AM, Larsson OM, et al. In vitro screening for anticonvulsant-induced teratogenesis in neural primary cultures and cell lines. Int J Dev Neurosci 1990;8:143-50.
71. Finnel RH, Wlodarczyk BC, Craig JC, Piedrahita JA, Bennet GD. Strain dependent alterations in the expression of folate pathway genes following teratogenic exposure to valproic acid in a mouse model. Am J Med Genet 1997;70:303-11.
72. Finnel RH, Vacha SJ, Mackler SA. Nucleic acid amplification technologies. In: Daston G, ed. Molecular and cellular methods in developmental toxicology. Boca Raton, FL: CRC Press, 1997:93-125.
73. Finnel RH, Junker WM, Wadman LK, Cabrera RM. Gene expression profiling within the developing neural tube. Neurochem Res 2002;27:1165-80.
74. Finnel RH, Bennett GD, Karras SB, Mohl VK. Common hierarchies of susceptibility to the induction of neural tube defects in mouse embryos by valproic acid and its 4-propyl-4-pentenoic acid metabolite. Teratology 1988;38:313-20.
75. Pippenger CE. Pharmacology of neural tube defects. Epilepsia 2003;44(suppl 3):24-32.
76. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 1992;41:1-7.
77. American Academy of Pediatrics. Folic acid for the prevention of neural tube defects. Pediatrics 1993;92:493-494.
78. Canadian Task Force on the Periodic Health Examination. Canadian guide to clinical preventive health care. Ottawa: Canada Communication Group, 1994:74-81.
79. Cornel MC, Erickson JD. Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly (SBA). Teratology 1997;55:134-137.
80. Institute of Medicine. Dietary reference intakes for thiamine, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, D.C.: National Academy Press, 1998:8-11.
81. Folic acid for the prevention of recurrent neural tube defects. Committee Opinion no. 120. Washington, DC: American College of Obstetricians and Gynecologists, 1993.
82. Use of folic acid for prevention of spina bifida and other neural tube defects 1983-1991. MMWR 1991;40:513-516.
83. Kishi T, Fujita N, Eguchi T, Ueda K. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy. J Neurol Sci 1997;145:109-12.
84. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 1996;61:8781-8797.
85. Centers for Disease Control and Prevention Folate status in women of childbearing age-United States, 1999. MMWR 2000;49:962-965.
86. Jacques PF, Selhub J, Bostom AG, Wilson PWF, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-1454.
87. Lawrence JM, Petitti DB, Watkins M, Umekubo MA. Trends in serum folate after food fortification. Lancet 1999;354:915-916.
88. Ray JG, Vermeulen M.J, Boss SC, Cole DEC. Increased red cell folate concentrations in women of reproductive age after Canadian folic acid food fortification. Epidemiology 2002;13:238-240.
89. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong L-YC. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981-2986.
90. Williams LJ, Mai CT, Edmonds LD, Shaw GM, Kirby R.S, Hobbs CA, Sever LE, Miller LA, Meaney FJ, Levitt M. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 2002;66:33-39.
91. Gucciardi E, Pietrusiak M-A, Reynolds DL, Rouleau J. Incidence of neural tube defects in Ontario1986-1999. Can Med Assoc J 2002;167:237-240.
92. Persad VL, Van den Hof MC, Dube JM, Zimmer P. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. Can Med Assoc J 2002;167:241-245.